Clinical ultrasound has evolved significantly since its introduction in the 1930s. Initially developed as a diagnostic tool, its therapeutic potential was quickly recognized. The introduction of High-Intensity Focused Ultrasound (HIFU) by Lynn et al. marked an important milestone, despite initial challenges with neurological side effects. With advances in medical imaging technology, particularly MRI, precise targeting became feasible, enabling safe and effective therapeutic use in various neurological conditions.